Skip to main content
Top
Published in: Obesity Surgery 9/2019

Open Access 01-09-2019 | Obesity | Original Contributions

Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery

Authors: Anne Christin Meyer-Gerspach, Ralph Peterli, Michael Moor, Philipp Madörin, Andreas Schötzau, Diana Nabers, Stefan Borgwardt, Christoph Beglinger, Oliver Bieri, Bettina K. Wölnerhanssen

Published in: Obesity Surgery | Issue 9/2019

Login to get access

Abstract

Background

Morbid obesity is a worldwide epidemic and is increasingly treated by bariatric surgery. Fatty liver is a common finding; almost half of all patients with non-alcoholic steatohepatitis develop steatohepatitis. Bariatric surgery improves steatohepatitis documented by liver biopsy and single voxel magnetic resonance imaging (MRI) techniques.

Objective

To investigate changes before and after bariatric surgery using whole organ MRI quantification of liver, visceral, and subcutaneous fat.

Setting

University of Basel Hospital and St. Clara Research Ltd, Basel, Switzerland.

Methods

Sixteen morbidly obese patients were evaluated by abdominal MRI-scanning before and 3, 6, 12, and 24 months after bariatric surgery to measure percentage liver fat (%-LF), total liver volume (TLV) and visceral and subcutaneous adipose tissues (VAT and SAT). Fasting plasma samples were taken for measurement of glucose, insulin, blood lipids, and liver biomarkers. In a control group of 12 healthy lean volunteers, the liver biomarker was also measured.

Results

The reproducibility of fat quantification by use of MRI was excellent. LF decreased significantly faster than VAT and SAT (%-LF vs. VAT p < 0.001 and %-LF vs. SAT p < 0.001). At certain time points, %-LF, VAT, and SAT were associated with changes in blood lipids and insulin.

Conclusions

MRI quantification offers excellently reproducible results in measurement of liver fat and visceral and subcutaneous adipose tissues. Liver fat decreased significantly faster than visceral or subcutaneous adipose tissue. Decrease in %-LF and VAT is associated with decrease in total cholesterol, LDL, and plasma insulin.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431–7.CrossRef Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431–7.CrossRef
2.
go back to reference Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32.CrossRefPubMed Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32.CrossRefPubMed
3.
go back to reference Katrina Loomis A et al. Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab. 2015:jc20153444. Katrina Loomis A et al. Body mass index and risk of non-alcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab. 2015:jc20153444.
4.
go back to reference Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–55.CrossRefPubMed Wong RJ, Aguilar M, Cheung R, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–55.CrossRefPubMed
5.
go back to reference Gonzalez-Cantero J, Martin-Rodriguez JL, Gonzalez-Cantero A, et al. Insulin resistance in lean and overweight non-diabetic Caucasian adults: study of its relationship with liver triglyceride content, waist circumference and BMI. PLoS One. 2018;13(2):e0192663.CrossRefPubMedPubMedCentral Gonzalez-Cantero J, Martin-Rodriguez JL, Gonzalez-Cantero A, et al. Insulin resistance in lean and overweight non-diabetic Caucasian adults: study of its relationship with liver triglyceride content, waist circumference and BMI. PLoS One. 2018;13(2):e0192663.CrossRefPubMedPubMedCentral
6.
go back to reference Korenblat KM, Fabbrini E, Mohammed BS, et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology. 2008;134(5):1369–75.CrossRefPubMed Korenblat KM, Fabbrini E, Mohammed BS, et al. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology. 2008;134(5):1369–75.CrossRefPubMed
7.
go back to reference Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of fatty liver. Endocr Rev. 2008;29(7):939–60.CrossRefPubMed Stefan N, Kantartzis K, Haring HU. Causes and metabolic consequences of fatty liver. Endocr Rev. 2008;29(7):939–60.CrossRefPubMed
8.
go back to reference Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed Sjostrom L et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741–52.CrossRefPubMed
9.
go back to reference Haufe S, Haas V, Utz W, et al. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care. 2013;36(11):3786–92.CrossRefPubMedPubMedCentral Haufe S, Haas V, Utz W, et al. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care. 2013;36(11):3786–92.CrossRefPubMedPubMedCentral
10.
go back to reference Joseph AE et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43(1):26–31.CrossRefPubMed Joseph AE et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43(1):26–31.CrossRefPubMed
11.
go back to reference Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51(3):433–45.CrossRefPubMed Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51(3):433–45.CrossRefPubMed
12.
go back to reference Mehta SH, Lau B, Afdhal NH, et al. Exceeding the limits of liver histology markers. J Hepatol. 2009;50(1):36–41.CrossRefPubMed Mehta SH, Lau B, Afdhal NH, et al. Exceeding the limits of liver histology markers. J Hepatol. 2009;50(1):36–41.CrossRefPubMed
13.
14.
15.
go back to reference Pooler BD et al. Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center study. Radiology. 2018:181134. Pooler BD et al. Monitoring fatty liver disease with MRI following bariatric surgery: a prospective, dual-center study. Radiology. 2018:181134.
16.
go back to reference Wald D, Teucher B, Dinkel J, et al. Automatic quantification of subcutaneous and visceral adipose tissue from whole-body magnetic resonance images suitable for large cohort studies. J Magn Reson Imaging. 2012;36(6):1421–34.CrossRefPubMed Wald D, Teucher B, Dinkel J, et al. Automatic quantification of subcutaneous and visceral adipose tissue from whole-body magnetic resonance images suitable for large cohort studies. J Magn Reson Imaging. 2012;36(6):1421–34.CrossRefPubMed
17.
go back to reference Wolf I, Vetter M, Wegner I, et al. The medical imaging interaction toolkit. Med Image Anal. 2005;9(6):594–604.CrossRefPubMed Wolf I, Vetter M, Wegner I, et al. The medical imaging interaction toolkit. Med Image Anal. 2005;9(6):594–604.CrossRefPubMed
18.
go back to reference Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28.CrossRefPubMed Yushkevich PA, Piven J, Hazlett HC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006;31(3):1116–28.CrossRefPubMed
19.
go back to reference Wildman RP et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.CrossRefPubMed Wildman RP et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617–24.CrossRefPubMed
20.
go back to reference Otto M, Färber J, Haneder S, et al. Postoperative changes in body composition--comparison of bioelectrical impedance analysis and magnetic resonance imaging in bariatric patients. Obes Surg. 2015;25(2):302–9.CrossRefPubMed Otto M, Färber J, Haneder S, et al. Postoperative changes in body composition--comparison of bioelectrical impedance analysis and magnetic resonance imaging in bariatric patients. Obes Surg. 2015;25(2):302–9.CrossRefPubMed
21.
go back to reference Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48.CrossRefPubMed Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48.CrossRefPubMed
22.
go back to reference Kaess BM, Pedley A, Massaro JM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55(10):2622–30.CrossRefPubMedPubMedCentral Kaess BM, Pedley A, Massaro JM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55(10):2622–30.CrossRefPubMedPubMedCentral
23.
go back to reference Hedderich DM, Hasenberg T, Haneder S, et al. Effects of bariatric surgery on non-alcoholic fatty liver disease: magnetic resonance imaging is an effective, non-invasive method to evaluate changes in the liver fat fraction. Obes Surg. 2017;27(7):1755–62.CrossRefPubMed Hedderich DM, Hasenberg T, Haneder S, et al. Effects of bariatric surgery on non-alcoholic fatty liver disease: magnetic resonance imaging is an effective, non-invasive method to evaluate changes in the liver fat fraction. Obes Surg. 2017;27(7):1755–62.CrossRefPubMed
24.
go back to reference Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2018;32(4):1675–82.CrossRefPubMed Luo RB, Suzuki T, Hooker JC, et al. How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc. 2018;32(4):1675–82.CrossRefPubMed
25.
go back to reference Friedrich-Rust M et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960–74.CrossRefPubMed Friedrich-Rust M et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology. 2008;134(4):960–74.CrossRefPubMed
26.
go back to reference Stevenson M, Lloyd-Jones M, Morgan MY, et al. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technol Assess. 2012;16(4):1–174.CrossRefPubMedPubMedCentral Stevenson M, Lloyd-Jones M, Morgan MY, et al. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation. Health Technol Assess. 2012;16(4):1–174.CrossRefPubMedPubMedCentral
27.
go back to reference Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.CrossRefPubMed
28.
go back to reference Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14(5):635–7.CrossRefPubMed Mottin CC, Moretto M, Padoin AV, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg. 2004;14(5):635–7.CrossRefPubMed
29.
go back to reference Kuhn JP et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39(6):1494–501.CrossRefPubMed Kuhn JP et al. Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging. 2014;39(6):1494–501.CrossRefPubMed
30.
go back to reference Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34(4):729–49.CrossRefPubMedPubMedCentral Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34(4):729–49.CrossRefPubMedPubMedCentral
31.
go back to reference Heath ML, Kow L, Slavotinek JP, et al. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism. 2009;58(6):753–8.CrossRefPubMed Heath ML, Kow L, Slavotinek JP, et al. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism. 2009;58(6):753–8.CrossRefPubMed
32.
go back to reference Gaborit B et al. Ectopic fat storage in the pancreas using H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes. 2014; Gaborit B et al. Ectopic fat storage in the pancreas using H-MRS: importance of diabetic status and modulation with bariatric surgery-induced weight loss. Int J Obes. 2014;
33.
go back to reference Verras CG et al. Serum fetuin-A levels are associated with serum triglycerides before and 6 months after bariatric surgery. Hormones (Athens). 2017;16(3):297–305. Verras CG et al. Serum fetuin-A levels are associated with serum triglycerides before and 6 months after bariatric surgery. Hormones (Athens). 2017;16(3):297–305.
34.
go back to reference Brix JM, Stingl H, Höllerl F, et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010;95(11):4877–81.CrossRefPubMed Brix JM, Stingl H, Höllerl F, et al. Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss. J Clin Endocrinol Metab. 2010;95(11):4877–81.CrossRefPubMed
35.
go back to reference Yang PJ, Ser KH, Lin MT, et al. Diabetes associated markers after bariatric surgery: Fetuin-A, but not matrix Metalloproteinase-7, is reduced. Obes Surg. 2015;25(12):2328–34.CrossRefPubMed Yang PJ, Ser KH, Lin MT, et al. Diabetes associated markers after bariatric surgery: Fetuin-A, but not matrix Metalloproteinase-7, is reduced. Obes Surg. 2015;25(12):2328–34.CrossRefPubMed
Metadata
Title
Quantification of Liver, Subcutaneous, and Visceral Adipose Tissues by MRI Before and After Bariatric Surgery
Authors
Anne Christin Meyer-Gerspach
Ralph Peterli
Michael Moor
Philipp Madörin
Andreas Schötzau
Diana Nabers
Stefan Borgwardt
Christoph Beglinger
Oliver Bieri
Bettina K. Wölnerhanssen
Publication date
01-09-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03897-2

Other articles of this Issue 9/2019

Obesity Surgery 9/2019 Go to the issue